Novartis AG (VIE:NOVN)
Austria · Delayed Price · Currency is EUR 130.70
+3.78 (2.98%)
At close: Feb 4, 2026
Novartis AG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 13,984 | 11,941 | 14,850 | 6,955 | 24,021 |
Depreciation & Amortization | - | 4,599 | 5,135 | 4,994 | 4,949 |
Loss (Gain) From Sale of Assets | - | -74 | -180 | -308 | -646 |
Asset Writedown & Restructuring Costs | - | 1,470 | 3,142 | 1,711 | 648 |
Loss (Gain) From Sale of Investments | - | 45 | 106 | 260 | -14,638 |
Loss (Gain) on Equity Investments | 1 | 38 | 13 | 11 | -214 |
Stock-Based Compensation | - | 1,044 | 865 | 791 | 700 |
Other Operating Activities | 8,219 | 369 | -7,808 | 195 | -607 |
Change in Accounts Receivable | - | -931 | -1,504 | -397 | -352 |
Change in Inventory | - | -225 | -546 | -560 | -102 |
Change in Accounts Payable | - | -105 | 479 | -181 | -111 |
Change in Other Net Operating Assets | -3,060 | -552 | -332 | -432 | -283 |
Operating Cash Flow | 19,144 | 17,619 | 14,458 | 14,236 | 15,071 |
Operating Cash Flow Growth | 8.65% | 21.86% | 1.56% | -5.54% | 10.41% |
Capital Expenditures | -1,548 | -1,366 | -1,060 | -916 | -1,066 |
Sale of Property, Plant & Equipment | 13 | 86 | 237 | 158 | 211 |
Cash Acquisitions | -147 | -4,018 | -3,561 | -832 | -259 |
Divestitures | -88 | 107 | 3 | -8 | 54 |
Sale (Purchase) of Intangibles | -2,188 | -2,368 | 262 | -1,153 | -804 |
Investment in Securities | 1,850 | 43 | 10,838 | 4,656 | 6,816 |
Other Investing Activities | -2,769 | 3 | -1,123 | -437 | -744 |
Investing Cash Flow | -4,877 | -7,513 | 5,596 | 1,468 | 4,208 |
Short-Term Debt Issued | 5 | 958 | 546 | 252 | - |
Long-Term Debt Issued | 6,098 | 6,143 | - | - | - |
Total Debt Issued | 6,103 | 7,101 | 546 | 252 | - |
Short-Term Debt Repaid | - | -289 | - | - | -3,547 |
Long-Term Debt Repaid | -3,673 | -2,422 | -2,481 | -2,837 | -2,440 |
Total Debt Repaid | -3,673 | -2,711 | -2,481 | -2,837 | -5,987 |
Net Debt Issued (Repaid) | 2,430 | 4,390 | -1,935 | -2,585 | -5,987 |
Issuance of Common Stock | 27 | 30 | 153 | 100 | 53 |
Repurchase of Common Stock | -9,212 | -8,331 | -8,719 | -10,652 | -3,057 |
Common Dividends Paid | -7,818 | -7,624 | -7,255 | -7,506 | -7,368 |
Other Financing Activities | -294 | -207 | 3,478 | 81 | 95 |
Financing Cash Flow | -14,867 | -11,742 | -14,278 | -20,562 | -16,264 |
Foreign Exchange Rate Adjustments | 576 | -298 | 100 | -32 | -266 |
Net Cash Flow | -24 | -1,934 | 5,876 | -4,890 | 2,749 |
Free Cash Flow | 17,596 | 16,253 | 13,398 | 13,320 | 14,005 |
Free Cash Flow Growth | 8.26% | 21.31% | 0.59% | -4.89% | 13.17% |
Free Cash Flow Margin | 31.05% | 31.42% | 28.71% | 30.65% | 31.85% |
Free Cash Flow Per Share | 9.00 | 7.99 | 6.40 | 6.06 | 6.20 |
Cash Interest Paid | - | 855 | 751 | 667 | 643 |
Cash Income Tax Paid | - | 2,258 | 2,787 | 1,702 | 1,856 |
Levered Free Cash Flow | 5,248 | 12,038 | 12,133 | 7,311 | 11,774 |
Unlevered Free Cash Flow | 5,963 | 12,667 | 12,667 | 7,811 | 12,266 |
Change in Working Capital | -3,060 | -1,813 | -1,903 | -1,570 | -848 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.